MAY 26, 2020 6:30 AM PDT

Nanoengineering Aids Bladder Cancer Detection

WRITTEN BY: Tara Fernandez

 

Australian innovators are working towards the next generation of bladder cancer diagnostics: a completely non-invasive “lab on a chip” device. These urgently needed clinical tools could make invasive cystoscopies (the current gold standard bladder cancer diagnostic that involves the insertion of a catheter) a thing of the past. Instead, the device would be able to sense the presence of cancer cells with a urine sample.

Bladder cancer survivors undergo up to four invasive cystoscopy examinations per year, which are expensive, require hospitalisation and can lead to complications such as sepsis and bleeding, says project lead Krasi Vasilev from the University of South Australia.

“Our technology offers patients a much safer, quicker and reliable detection – without additional discomfort, pain and risk of complication,” adds Vasilev, a biomedical engineer who specializes in nanoengineered surfaces for clinical applications.

Bladder cancer represents one of the most common cancers in the United States, which begins as cells lining the inner surface of the organ begin to grow abnormally. Factors such as smoking, chemical exposure, chronic irritation and parasitic infections can contribute to the development of the disease. Bladder cancer is highly treatable, but it has to be diagnosed early and monitored closely following therapy as they have a high recurrence rate — 75 percent of bladder cancers recur within 5 years of treatment.

The new test combines two cutting-edge biomedical engineering techniques: high-precision moulding and microfluidics (tiny fluid-containing channels with dimensions at the microscale). Biological specimens such as urine are exposed to a 20-nanometer-thick polymer coating on a substrate. Antibodies are used to detect the presence of specific proteins uniquely found on the surface of bladder cancer cells. Biosensors and micro-optics positively identifies the presence of these cancer cells in the sample.

 

 

“We’re looking to extend this technology to diagnose other diseases – renal disease, prostate and kidney cancers, urinary tract infections as well as rapid and cost-effective detection of viruses such as Covid-19,” said Vasilev. His team was recently awarded $2 million dollars under the National Health and Medical Research Council 2021 Investigator Grants to develop and commercialize these technologies.

 

Sources: University of South Australia, Photodiagnosis Photodyn. Ther.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 14, 2020
Cardiology
Changing Your Doctor Can Cause Confusion in Your Chart
JUL 14, 2020
Changing Your Doctor Can Cause Confusion in Your Chart
Nowadays, many people’s lifestyle sees them move on to better pastures every few years. Staying in one place is no ...
JUL 19, 2020
Cardiology
Common Biomarker Could Predict Heart Disease
JUL 19, 2020
Common Biomarker Could Predict Heart Disease
Heart failure is usually associated with conditions like high blood pressure and coronary artery disease. But there may ...
SEP 17, 2020
Clinical & Molecular DX
Blood Vessels on a Chip Test Clotting
SEP 17, 2020
Blood Vessels on a Chip Test Clotting
Blood clotting, also known as coagulation, is a critical biological mechanism to prevent excessive blood loss in the eve ...
OCT 01, 2020
Cardiology
Investigating Inflammation in Coronary Artery Bypass Grafts
OCT 01, 2020
Investigating Inflammation in Coronary Artery Bypass Grafts
The heart is a vital part of the body that can last one hundred years, yet even a small change can cause massive consequ ...
OCT 17, 2020
Clinical & Molecular DX
Imaging Innovation Set to Ease the Pain of Osteoarthritis
OCT 17, 2020
Imaging Innovation Set to Ease the Pain of Osteoarthritis
In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness ...
OCT 21, 2020
Cancer
Can Excess Fructose Cause Liver Cancer?
OCT 21, 2020
Can Excess Fructose Cause Liver Cancer?
Hepatocellular carcinoma, aka liver cancer, is an ever-increasing issue in the western world. While the lion’s sha ...
Loading Comments...